Novo and Sanofi expects to make fierce competition over the next term’s insulin
The strong of insulin are going to compete in its market for the next term. They have not been unveiled, but will be launched within this year to preoccupy the market.
According to the industry concerned on the 27th, Novo Nordisk and Sanofi are making fierce competition to preoccupy the insulin ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
